I want a TB test that works for me
Latest News

Heat-stable ritonavir approved, ending treatment stranglehold for people living with HIV/AIDSread more

 

Make It Happen Campaign Update: UNITAID Board still discussing finer details of the Patent Pool Entity read more

 

New European Parliament Working Group on Innovation & Access launches with support of Access Campaign  read more

 

U.S. health care legislation could limit access read more

 

MSF responds to World Health Organization’s new HIV treatment guidelines read more

 

MSF sends letter to EU Ministers of Health regarding antibiotic resistance read more

 

 

 





World Health Assembly May 2008

Representatives from more than 150 countries are meeting in Geneva this week at the World Health Assembly. One of their tasks is to complete the work of the Intergovernmental Working Group on Innovation, Public Health and Intellectual Property (IGWG) on a deal both to increase access to medicines in developing countries and to reform a system of medical research and development that has failed to deliver new treatments to patients in the developing world. Access Campaign director, Dr Tido von Schoen-Angerer, says there's still a window of opportunity  Listen to Dr von Schoen-Angerer 


© Donald Weber

Putting Patients First:   MSF collection of interviews and essays on some of the gaps in medical research and access and some proposals to reform the current system

Read more about the Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG)  

Listen to the Access Campaign's director, Dr. Tido von Schoen-Angerer explaining what's at stake at the IGWG

'What we wanted to see was governments prescribe some change to a broken system, but they have not risen to the challenge. Concrete proposals to ensure urgently needed drugs and diagnostics are developed for developing country diseases have not received support.  Considering the colossal needs we see in MSF daily practice, this is a lost opportunity.’ Dr Tido von Schoen-Angerer

Read MSF's statement at the end of the April IGWG talks